Analystreport

Recro Pharma Inc (NASDAQ: REPH) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Recro Pharma, Inc.  (REPH) 
Last recro pharma, inc. earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.recropharma.com